• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.07% Nasdaq Up 0.32%

    Keryx Biopharmaceuticals Inc. (KERX)

    -NasdaqCM
    6.42 Up 0.22(3.55%) Aug 28, 4:00PM EDT
    |After Hours : 6.35 Down 0.07 (1.09%) Aug 28, 7:02PM EDT
    Add to Portfolio
    Prev Close:6.20
    Open:6.20
    Bid:N/A
    Ask:6.62 x 200
    1y Target Est:15.30
    Beta:6.69727
    Earnings Date:Nov 4 - Nov 9 (Est.)
    Day's Range:6.20 - 6.64
    52wk Range:5.25 - 18.42
    Volume:1,062,670
    Avg Vol (3m):1,596,240
    Market Cap:675.20M
    P/E (ttm):N/A
    EPS (ttm):-1.34
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    KERXUp 3.55%675.20M
    BAXUp 0.41%21.14B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):144.45
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.02
    Quarterly EPS Est (Sep-15) :-0.26
    Mean Recommendation*:2.4
    PEG Ratio (5 yr expected):-0.05

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on providing therapies for patients with renal disease in the United States. Its lead product Auryxia (ferric citrate), an oral, ferric iron-based compound that has the capacity ... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback